Personal Information
Name – Surname:Mehmet Akif Durmuş
Academic Title / Position: Specialist Physician (MD)
Current Position: Specialist of Medical Microbiology, Başakşehir Çam and Sakura City Hospital
Education
2006–2012 – Faculty of Medicine, Düzce University – MD
2014–2018 – Medical Microbiology, Istanbul University, Istanbul Faculty of Medicine – Specialization
2018–2020 – Medical Microbiology & Basic Immunology, Istanbul University, Istanbul Faculty of Medicine – Subspecialty
Professional Experience
2021 – Present
Başakşehir Çam and Sakura City Hospital, Specialist, Department of Medical Microbiology
2025– Present
Başakşehir Çam and Sakura City Hospital, Director, Department of Medical Microbiology
General Information About Clinical Research
2017 – Investigation of carbapenem resistance in Klebsiella pneumoniae strains by phenotypic and genotypic methods – Principal Investigator
2019 – Evaluation of measles, pneumococcus and hepatitis B antibody levels before and during biological therapy in previously vaccinated patients: a multicenter prospective study – Co-Investigator
2020 – Brucella seroprevalence and risk factors in patients admitted to a university hospital – Co-Investigator
2020 – Resistance profile of Pseudomonas aeruginosa isolated from lower respiratory tract samples – Co-Investigator
2023 – Urinary HSP70 improves diagnostic accuracy for urinary tract infection in children: UTILISE study – Co-Investigator
2023 – Urine soluble TLR4 levels may contribute to predict urinary tract infection in children: UTILISE study – Co-Investigator
2024 – Artificial intelligence applications for immunology laboratory: image analysis and classification study of IIF photos – Principal Investigator
2024 – Investigation of biofilm formation, anti-quorum sensing activity and antimicrobial resistance in Corynebacterium species isolated from clinical samples – Co-Investigator
2024 – The relationship between urinary heat shock protein 70 and congenital anomalies of the kidney and urinary tract: UTILISE study – Co-Investigator
2025 – Performance assessment of the Concepta automated ANA detection system in routine clinical samples – Principal Investigator
2025 – Comparison of artificial intelligence applications and commercial system performances using selected ANA IIF images – Principal Investigator
2025 – Are new β-lactam/β-lactamase inhibitor combinations promising against carbapenem-resistant K. pneumoniae isolates? – Co-Investigator
2025 – Frequency of the AC-2 pattern’s new variant (AC-30) and detection of different immunological relationships – Principal Investigator
2025- Rational test request in autoimmune rheumatological disease diagnosis evaluation of immunoblot requests with anti-nuclear antibody indirect immunofluorescence test requests